Across TCGA pan-cancer cohorts, NBEAP1 RNA is linked to patient survival in 27 of 34 cancer types, making it the most broadly survival-associated NBEAP1 data layer.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher NBEAP1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated NBEAP1 expression acts as an unfavorable survival marker, although some lineages such as ACC and LGG show a favorable association.
KIRC, HNSC, and KICH are the cancer types where NBEAP1 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.